Trial Profile
The benefits and side effects of denosumab for patients with bone metastases from solid tumours
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Jan 2016
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Solid tumours
- Focus Therapeutic Use
- 22 Jan 2016 New trial record